LeadingBiotech: South CEO is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Susan Nichols
CEO at Falcon Therapeutics


As the CEO of Falcon Therapeutics, Susan Nichols is responsible for running all facets of the business.    Susan has a proven executive management track record and over twenty  years of corporate management and leadership experience in high growth biotech, entering the cell therapy arena in 2010.   Susan brings a unique perspective having served in global executive management roles with early stage , emerging, and fortune 500 companies such as Thermo Fisher, Hitachi Chemical, Baebies, and Invetech, a division of Fortive Corporation.  She developed and oversaw partnerships with pharmaceutical companies and life science companies to advance drug development and the manufacturing platforms that enable commercial success. Susan was able to shepherd scale-up efforts of cell therapies through all phases of clinical trials and into commercialization. In support of early stage Life Science companies, she successfully established funding relationships with VC’s, Private Investment Groups, Angel Investors, Philanthropic Alliances, Non-traditional Financing, Royalty Deals, Licensing Opportunities, and Strategic Alliances.  Throughout her career, she has successfully built market opportunities, product platforms, high performing teams, and pipelines.  Susan joined Falcon Therapeutics, Inc. in January 2018 to apply her experience establishing new markets for cell therapies, fundraising for early stage life science companies, and establishing partnerships with pharmaceutical companies to support Falcon’s next steps toward regulatory approval and commercialization of its new promising Trilogy cell platform targeting solid tumor cancers.  Susan serves on the Rare Disease Forum Steering Committee and the board of the North Carolina Rare Disease Innovations Institute.  Susan’s has a passion for ensuring the patient voice is heard and understood and advancing initiatives ensuring patient’s access to resources and therapies.

Susan Nichols's Network

Agenda Sessions

  • Accelerating Innovation to the Patient: Academic & Industry Partnerships

    , 3:00pm